Intellectual Property India Publishes Patent Application for 'Studies On Preformulation Characteristics And Production Of Pazopanib Nanoparticles' Filed by Mohan Babu University

MUMBAI, India, May 1 -- Intellectual Property India has published a patent application (202641048049 A) filed by Mohan Babu University, Tirupati, Andhra Pradesh, on April 15, for 'studies on preformulation characteristics and production of pazopanib nanoparticles.'

Inventor(s) include Mrs. M. Keerthi; and Dr. Shanmugham Vippamakula.

The application for the patent was published on May 1, under issue no. 18/2026.

According to the abstract released by the Intellectual Property India: "Pazopanib is an oral multi-targeted tyrosine kinase inhibitor used in the treatment of renal cell carcinoma. Despite its clinical efficacy, its poor aqueous solubility and low bioavailability significantly limit its therapeutic potential. The present study was...